Wagner grading 1-5 for diabetes foot
Conditions
Interventions
A prospective metabonomic study of peripheral blood and tissue in patients with diabetes foot:Not applicable, this project is an observational trial with no intervention measures
Sponsors
Nanjing Nanyao Pharmaceutical Technology Co., Ltd
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Serum samples are sourced from residual samples from clinical testing; The tissue samples are sourced from residual skin tissue samples during clinical surgical procedures; 2) Meet storage requirements, that is, serum samples must be stored at room temperature after collection and centrifuged within 12 hours after collection. Then store it continuously at -60 ? until analysis is conducted; After the collection of organizational samples, they must be stored at -60 ? for 1 hour until analysis is carried out; 3) Patient age = 18 years old, gender not limited; 4) When screening, the body mass index (BMI) is between 18.5-30 kg/m2 (inclusive); 5)Patients with clinically diagnosed diabetes foot.
Exclusion criteria
Exclusion criteria: 1) The serum sample shows coagulation or hemolysis phenomena; 2) Incorrect collection or storage of serum or tissue samples; 3) Screening for hyperthyroidism or hypothyroidism that has not received good treatment; 4) Hepatitis B surface antigen positive, hepatitis C antibody positive, HIV antibody positive, and/or Treponema pallidum antibody positive; 5) Patients with major physical diseases such as neurological disorders, traumatic brain injury, cardiovascular and cerebrovascular diseases, and severe liver and kidney dysfunction; 6) Pregnant or lactating women; 7) Merge with other significant medical histories; 8) Currently receiving hormone therapy; 9) Researchers believe that patients with other factors are not suitable to participate in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detecting multiple metabolites in serum; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detecting multiple metabolites in the organization; | — |
Countries
China
Contacts
Public ContactXu Gang
Subei People's Hospital
Outcome results
None listed